Development of GPC3-Specific Chimeric Antigen Receptor-Engineered Natural Killer Cells for the Treatment of Hepatocellular Carcinoma
2021 ◽
Vol 13
(12)
◽
pp. 2029-2037
Keyword(s):
2017 ◽
Vol 25
(12)
◽
pp. 2607-2619
◽
Keyword(s):
2018 ◽
Keyword(s):